West Pharmaceutical Services Inc
corporate_fare Company Profile
West Pharmaceutical Services Inc (NYSE:WST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for WST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-23, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for WST spans 10-Q, 8-K, 8-K/A, DEF 14A.
Recent high-impact activity:
- West Pharmaceutical Reports Strong Q2 Results, Details Cyber Incident Impact, and Boosts Share Buybacks
- West Pharma Beats Q2 Estimates, Raises Full-Year Sales and EPS Guidance
- West Pharma Q2 Profit Jumps 17%, Guides FY EPS to $8.85-$9.05
- West Pharma Guides FY Sales to $3.35B-$3.38B, Above Consensus
- West Pharmaceutical Services Appoints Michel Lagarde as New President and CEO
Financial Snapshot
Short Interest & Short Volume
4.51 days to coverFINRA reported short interest of 2,378,099 shares in WST as of the September 15, 2026 settlement, a 8.3% increase from the prior period — about 4.5 days to cover at its recent average daily volume. On October 2, 2026, 66.6% of WST volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.